SN

Sandhya Nandiraju - Profile

Sandhya Nandiraju, Director and Whole-Time Director, with 7 companies across 2 industries.

About Sandhya Nandiraju

Sandhya Nandiraju has 9 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 4 companies, including Vinda Healthcare Private Limited and Serind Pharma Private Limited. Formerly with 3 companies, such as Avidia Pharma Labs Llp and Clinsync Clinical Research Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.

Current Companies 4
Past Companies 3
Total Affiliations 7
Oldest Company Age 15
Companies Associated with Sandhya Nandiraju
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Sandhya Nandiraju?

Sandhya Nandiraju has 9 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 4 companies, including Vinda Healthcare Private Limited and Serind Pharma Private Limited. Formerly with 3 companies, such as Avidia Pharma Labs Llp and Clinsync Clinical Research Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.

What is Sandhya Nandiraju's role in current companies?

Sandhya Nandiraju is associated with 4 companies as Director and Whole-Time Director.

What industries does Sandhya Nandiraju specialize in?

Sandhya Nandiraju has expertise in Healthcare, General Business.

How many years of experience does Sandhya Nandiraju have?

Sandhya Nandiraju has 9 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available